Lido Advisors’s Mustang Bio MBIO Stock Holding History

Lido Advisors’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-13	Closed	-$26K	–	1024
2021 Q3	$26K	Hold	13	–	–	﹤0.01%	953
2021 Q2	$33K	Hold	13	–	–	﹤0.01%	899
2021 Q1	$33K	Sell	13 -14	-52%	-$41.6K	﹤0.01%	831
2020 Q4	$75K	Sell	27 -17	-39%	-$40.6K	﹤0.01%	796
2020 Q3	$104K	Hold	44	–	–	﹤0.01%	612
2020 Q2	$105K	Hold	44	–	–	﹤0.01%	575
2020 Q1	$88K	Buy	+44	New	+$113K	﹤0.01%	562

Other funds holding MBIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Lido Advisors's MBIO Position: Q4 2021 in Review

Lido Advisors sold out of Mustang Bio (MBIO) in Q4 2021, closing a stake of 13 shares — an estimated $26K sold.

Lido Advisors first reported a position in MBIO in Q1 2020 and held it in 7 quarters. The position peaked at $105K in Q2 2020. 83 funds tracked by Wall St. Rank hold MBIO as of Q4 2021.

Lido Advisors reported no remaining Mustang Bio position as of Q4 2021 after selling out during the quarter.
Lido Advisors sold 13 Mustang Bio shares in Q4 2021, an estimated $26K.
Lido Advisors first reported a position in Mustang Bio in Q1 2020 and held it in 7 quarters.
Lido Advisors's Mustang Bio position peaked at $105K in Q2 2020.
83 funds tracked by Wall St. Rank held Mustang Bio as of Q4 2021.

Based on Lido Advisors's 13F filing for Q4 2021, filed 15 Feb 2022.